Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Hydromorphone-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia: a Randomized Controlled Trial

NCT06036797 is registered in ClinicalTrials.gov with Maternal and Child Health Hospital of Hubei Province as lead sponsor.

NCT NCT06036797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06036797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Hydromorphone-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia: a Randomized Controlled Trial
Lead sponsor
Maternal and Child Health Hospital of Hubei Province
Phase
Phase 2
Overall status
Unknown status
Start date
September 17, 2023
Completion date
October 17, 2023
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

analgesia, labor pain